LT-002-158 tablets
Sponsors
Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.
Conditions
Atopic Dermatitis (AD)Hidradenitis Suppurativa (HS)
Phase 1
A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis
RecruitingNCT06931990
Start: 2025-06-04End: 2028-03-30Target: 24Updated: 2026-08-27
A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis Suppurativa
RecruitingNCT06932003
Start: 2025-07-08End: 2028-12-30Target: 12Updated: 2026-08-27